Comments
Loading...

Cartesian Therapeutics

RNACNASDAQ
Logo brought to you by Benzinga Data
Q3 2024 Earnings were released on Thu Nov 7th, before the market open

Cartesian Therapeutics (NASDAQ:RNAC) Stock Quotes, Forecast and News Summary

Cartesian Therapeutics Stock (NASDAQ: RNAC) stock price, news, charts, stock research, profile.

Open$16.80
Close-
Volume / Avg.196.37K / 93.85K
Day Range$15.50 - $16.80
52 Wk Range11.67 - 42.60
Market Cap$419.35M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
36
Short Interest
12.08%
Days to Cover28.06

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
RNAC
VALN

FAQ

Q

How do I buy Cartesian Therapeutics (RNAC) stock?

A

You can purchase shares of Cartesian Therapeutics (NASDAQ:RNAC) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Cartesian Therapeutics (RNAC) competitors?

Q

What is the forecast, or price target, for Cartesian Therapeutics (RNAC) stock?

A

Cartesian Therapeutics has a consensus price target of $40.80.

Q

What is the current price for Cartesian Therapeutics (RNAC)?

A

The stock price for Cartesian Therapeutics (NASDAQ: RNAC) is $16.5 last updated November 14, 2024 at 1:06 PM EST.

Q

Does Cartesian Therapeutics (RNAC) pay a dividend?

A

There are no upcoming dividends for Cartesian Therapeutics.

Q

When is Cartesian Therapeutics (NASDAQ:RNAC) reporting earnings?

A

Cartesian Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.

Q

Is Cartesian Therapeutics (RNAC) going to split?

A

There is no upcoming split for Cartesian Therapeutics.

Q

What sector and industry does Cartesian Therapeutics (RNAC) operate in?

A

Cartesian Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch